Enact Holdings Confirms Strong Q1 Earnings, 14% Dividend Hike, and Substantial Share Repurchases

summarizeSummary

Enact Holdings confirmed strong Q1 2026 results with increased EPS and New Insurance Written, alongside significant share repurchases and a 14% dividend hike, building on its prior 8-K announcement.

check_boxKey Events

• Strong Q1 Earnings Growth

  Diluted EPS increased by 9.3% to $1.18, and net income rose by 1.2% to $167.772 million for Q1 2026 compared to Q1 2025, confirming the preliminary results announced on May 5th.

• Significant New Insurance Written (NIW)

  New Insurance Written (NIW) grew by over 30% to $12.786 billion in Q1 2026, primarily due to higher mortgage refinancing activity.

• Substantial Share Repurchases

  The company repurchased $93.196 million in common stock during Q1 2026 and an additional $29.8 million through April 30, 2026, under its existing $500 million authorization.

• Quarterly Dividend Increase

  The quarterly dividend was increased by 14% to $0.24 per common share, payable in June 2026, demonstrating a continued commitment to shareholder returns.

auto_awesomeAnalysis

Enact Holdings, Inc. has filed its Q1 2026 10-Q, confirming the strong financial results and capital allocation decisions previously announced in its May 5th 8-K filing. The company reported a 9.3% increase in diluted EPS to $1.18 and a 1.2% rise in net income to $167.772 million year-over-year. New Insurance Written (NIW) saw robust growth, increasing by over 30% to $12.786 billion, driven by higher mortgage refinancing originations. The company continued its significant capital return strategy, repurchasing $93.196 million in common stock during Q1 2026 and an additional $29.8 million through April 30, 2026. Furthermore, the quarterly dividend was increased by 14% to $0.24 per share, payable in June 2026. While the loss ratio increased to 15% from 12% and delinquent loans rose, these were partially offset by favorable reserve adjustments and the company maintains a strong capital position with a PMIERs sufficiency ratio of 162%. The stock is currently trading near its 52-week high, reflecting positive investor sentiment around these results and capital returns.